back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2018-05-16 Tx date 2018-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-3,770.25
-7,500 vol $0.50 each |
0 | |
| Filed 2018-05-16 Tx date 2018-05-06 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-6,107 vol |
36,107 | |
| Filed 2018-05-16 Tx date 2018-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$3,770
+7,500 vol $0.50 each |
167,609 | |
| Filed 2017-12-12 Tx date 2017-12-08 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$289.00
+200 vol $1.45 each |
99,200 | |
| Filed 2017-12-12 Tx date 2017-12-08 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,249
+5,000 vol $1.45 each |
99,000 | |
| Filed 2017-12-12 Tx date 2017-12-08 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,680
+8,000 vol $1.46 each |
94,000 | |
| Filed 2017-12-12 Tx date 2017-12-08 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,917
+2,000 vol $1.46 each |
86,000 | |
| Filed 2017-12-12 Tx date 2017-12-08 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,147
+4,800 vol $1.49 each |
84,000 | |
| Filed 2017-12-12 Tx date 2017-12-08 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$297.00
+200 vol $1.49 each |
79,200 | |
| Filed 2017-12-12 Tx date 2017-12-08 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$35,890
+24,250 vol $1.48 each |
79,000 | |
| Filed 2017-12-12 Tx date 2017-12-08 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,106
+750 vol $1.48 each |
54,750 | |
| Filed 2017-12-12 Tx date 2017-12-08 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,220
+3,600 vol $1.45 each |
104,000 | |
| Filed 2017-12-12 Tx date 2017-12-08 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,738
+1,200 vol $1.45 each |
100,400 | |
| Filed 2017-07-17 Tx date 2017-06-13 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-6,107 vol |
42,214 | |
| Filed 2017-06-19 Tx date 2017-06-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,181
+15,000 vol $1.15 each |
160,109 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$58,525
+50,000 vol $1.17 each |
145,109 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
48,321 | |
| Filed 2017-05-12 Tx date 2017-05-11 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
7,500 | |
| Filed 2017-05-12 Tx date 2017-05-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-10,575
-7,500 vol $1.41 each |
0 | |
| Filed 2017-05-12 Tx date 2017-05-03 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$10,575
+7,500 vol $1.41 each |
95,109 | |
| Filed 2017-03-17 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
60,719 | ||
| Filed 2017-03-17 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-17 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-17 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-17 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-17 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
4,000 | ||
| Filed 2017-03-17 Tx date 2017-03-15 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$102,249
+45,000 vol $2.27 each |
54,000 | |
| Filed 2016-06-20 Tx date 2016-06-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
7,500 | |
| Filed 2016-06-20 Tx date 2016-06-16 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
33,321 | |
| Filed 2016-06-14 Tx date 2016-06-10 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$33,616
+9,390 vol $3.58 each |
91,609 | |
| Filed 2016-06-14 Tx date 2016-06-10 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
$-33,616.20
-9,390 vol $3.58 each |
0 | |
| Filed 2016-05-17 Tx date 2016-05-12 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$641.95
+185 vol $3.47 each |
80,504 | |
| Filed 2016-05-17 Tx date 2016-05-12 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,753
+3,100 vol $3.47 each |
80,319 | |
| Filed 2016-05-17 Tx date 2016-05-12 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,725
+2,500 vol $3.49 each |
77,219 | |
| Filed 2016-05-17 Tx date 2016-05-12 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: Laura A Kirsch Trust, dated 4/12/2000 (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,449
+5,000 vol $3.49 each |
5,000 | |
| Filed 2016-05-17 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: Laura A Kirsch Trust, dated 4/12/2000 (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-17 Tx date 2016-05-12 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$35,000
+10,000 vol $3.50 each |
74,719 | |
| Filed 2016-05-17 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
64,719 | ||
| Filed 2016-05-17 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-17 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-17 Tx date 2016-05-12 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,366
+5,000 vol $3.47 each |
5,000 | |
| Filed 2016-05-17 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Holder: IRA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-17 Tx date 2016-05-12 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,053
+1,715 vol $3.53 each |
82,219 | |
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
9,390 | ||
| Filed 2016-02-18 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
55,329 | ||
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
18,321 | ||
| Filed 2016-02-12 Tx date 2016-02-05 |
$ARZ
Aralez Pharmaceuticals Inc. |
Kirsch, Arthur S.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
64,719 |